• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭患者基于模型的共病聚类:与临床结局和医疗资源利用的关联

Model-based comorbidity clusters in patients with heart failure: association with clinical outcomes and healthcare utilization.

作者信息

Gulea Claudia, Zakeri Rosita, Quint Jennifer K

机构信息

Department of Population Health, National Heart and Lung Institute, Imperial College London, London, UK.

NIHR Imperial Biomedical Research Centre, London, UK.

出版信息

BMC Med. 2021 Jan 18;19(1):9. doi: 10.1186/s12916-020-01881-7.

DOI:10.1186/s12916-020-01881-7
PMID:33455580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7812726/
Abstract

BACKGROUND

Comorbidities affect outcomes in heart failure (HF), but are not reflected in current HF classification. The aim of this study is to characterize HF groups that account for higher-order interactions between comorbidities and to investigate the association between comorbidity groups and outcomes.

METHODS

Latent class analysis (LCA) was performed on 12 comorbidities from patients with HF identified from administrative claims data in the USA (OptumLabs Data Warehouse®) between 2008 and 2018. Associations with admission to hospital and mortality were assessed with Cox regression. Negative binomial regression was used to examine rates of healthcare use.

RESULTS

In a population of 318,384 individuals, we identified five comorbidity clusters, named according to their dominant features: low-burden, metabolic-vascular, anemic, ischemic, and metabolic. Compared to the low-burden group (minimal comorbidities), patients in the metabolic-vascular group (exhibiting a pattern of diabetes, obesity, and vascular disease) had the worst prognosis for admission (HR 2.21, 95% CI 2.17-2.25) and death (HR 1.87, 95% CI 1.74-2.01), followed by the ischemic, anemic, and metabolic groups. The anemic group experienced an intermediate risk of admission (HR 1.49, 95% CI 1.44-1.54) and death (HR 1.46, 95% CI 1.30-1.64). Healthcare use also varied: the anemic group had the highest rate of outpatient visits, compared to the low-burden group (IRR 2.11, 95% CI 2.06-2.16); the metabolic-vascular and ischemic groups had the highest rate of admissions (IRR 2.11, 95% CI 2.08-2.15, and 2.11, 95% CI 2.07-2.15) and healthcare costs.

CONCLUSIONS

These data demonstrate the feasibility of using LCA to classify HF based on comorbidities alone and should encourage investigation of multidimensional approaches in comorbidity management to reduce admission and mortality risk among patients with HF.

摘要

背景

合并症会影响心力衰竭(HF)的预后,但目前的HF分类中并未体现这一点。本研究的目的是对合并症之间存在高阶相互作用的HF组进行特征描述,并调查合并症组与预后之间的关联。

方法

对2008年至2018年期间从美国行政索赔数据(OptumLabs Data Warehouse®)中识别出的HF患者的12种合并症进行潜在类别分析(LCA)。采用Cox回归评估与住院和死亡率的关联。使用负二项回归来检查医疗保健使用率。

结果

在318384名个体的人群中,我们识别出五个合并症集群,根据其主要特征命名为:低负担、代谢-血管、贫血、缺血和代谢。与低负担组(合并症最少)相比,代谢-血管组(表现出糖尿病、肥胖和血管疾病模式)的住院(风险比[HR] 2.21,95%置信区间[CI] 2.17 - 2.25)和死亡(HR 1.87,95% CI 1.74 - 2.01)预后最差,其次是缺血组、贫血组和代谢组。贫血组的住院(HR 1.49,95% CI 1.44 - 1.54)和死亡(HR 1.46,95% CI 1.30 - 1.64)风险处于中等水平。医疗保健使用情况也有所不同:与低负担组相比,贫血组的门诊就诊率最高(发病率比[IRR] 2.11,95% CI 2.06 - 2.16);代谢-血管组和缺血组的住院率(IRR 2.11,95% CI 2.08 - 2.15和2.11,95% CI 2.07 - 2.15)和医疗费用最高。

结论

这些数据证明了仅基于合并症使用LCA对HF进行分类的可行性,并应鼓励对合并症管理中的多维方法进行研究,以降低HF患者的住院和死亡风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0731/7812726/8b27611a7df7/12916_2020_1881_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0731/7812726/27d56031ac09/12916_2020_1881_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0731/7812726/0b1346b72a50/12916_2020_1881_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0731/7812726/8b27611a7df7/12916_2020_1881_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0731/7812726/27d56031ac09/12916_2020_1881_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0731/7812726/0b1346b72a50/12916_2020_1881_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0731/7812726/8b27611a7df7/12916_2020_1881_Fig3_HTML.jpg

相似文献

1
Model-based comorbidity clusters in patients with heart failure: association with clinical outcomes and healthcare utilization.心力衰竭患者基于模型的共病聚类:与临床结局和医疗资源利用的关联
BMC Med. 2021 Jan 18;19(1):9. doi: 10.1186/s12916-020-01881-7.
2
Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.11 个亚洲地区心力衰竭患者的多病共存情况:使用 ASIAN-HF 注册研究的前瞻性队列研究。
PLoS Med. 2018 Mar 27;15(3):e1002541. doi: 10.1371/journal.pmed.1002541. eCollection 2018 Mar.
3
The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial - insights from ASCEND-HF.ASCEND-HF 研究中的非心脏合并症负担及其与临床结局的关系。
Eur J Heart Fail. 2020 Jun;22(6):1022-1031. doi: 10.1002/ejhf.1795. Epub 2020 Mar 25.
4
Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.植入式心脏复律除颤器用于一级预防的心力衰竭患者合并症与预后的关系
J Am Heart Assoc. 2015 Aug 6;4(8):e002061. doi: 10.1161/JAHA.115.002061.
5
Disease-modifying therapy and hospitalization risk in heart failure patients.心力衰竭患者的疾病改善治疗与住院风险
Am J Manag Care. 2015 Jan;21(1):39-47.
6
Outcomes associated with comorbid atrial fibrillation and heart failure in Medicare beneficiaries with acute coronary syndrome.医疗保险急性冠脉综合征受益人中合并心房颤动和心力衰竭的相关结局。
BMC Health Serv Res. 2014 Feb 20;14:80. doi: 10.1186/1472-6963-14-80.
7
Trends in Cause-Specific Outcomes Among Individuals With Type 2 Diabetes and Heart Failure in the United Kingdom, 1998-2017.英国 1998-2017 年 2 型糖尿病合并心力衰竭患者的病因特异性结局趋势。
JAMA Netw Open. 2019 Dec 2;2(12):e1916447. doi: 10.1001/jamanetworkopen.2019.16447.
8
Health care resource utilization among patients with T2D and cardiovascular-, heart failure-, or renal-related hospitalizations.患有 2 型糖尿病且有心血管、心力衰竭或肾脏相关住院史的患者的医疗资源利用情况。
Am J Manag Care. 2020 Jun 1;26(6):e166-e171. doi: 10.37765/ajmc.2020.43491.
9
Comorbidity health pathways in heart failure patients: A sequences-of-regressions analysis using cross-sectional data from 10,575 patients in the Swedish Heart Failure Registry.心力衰竭患者的合并症健康途径:使用来自瑞典心力衰竭登记处的 10575 名患者的横断面数据进行的序列回归分析。
PLoS Med. 2018 Mar 27;15(3):e1002540. doi: 10.1371/journal.pmed.1002540. eCollection 2018 Mar.
10
Comparison of Machine Learning Methods With Traditional Models for Use of Administrative Claims With Electronic Medical Records to Predict Heart Failure Outcomes.利用电子病历中的行政索赔数据进行机器学习方法与传统模型预测心力衰竭结局的比较。
JAMA Netw Open. 2020 Jan 3;3(1):e1918962. doi: 10.1001/jamanetworkopen.2019.18962.

引用本文的文献

1
Molecular Phenogroups in Heart Failure: Large-Scale Proteomics in a Population-Based Cohort.心力衰竭中的分子表型组:基于人群队列的大规模蛋白质组学研究
Circ Genom Precis Med. 2025 Jul 16:e004953. doi: 10.1161/CIRCGEN.124.004953.
2
Cluster analysis of diet and lifestyle factors associated with metabolic dysfunction-associated steatotic liver disease: findings from Korean Genome and Epidemiology Study.与代谢功能障碍相关脂肪性肝病相关的饮食和生活方式因素的聚类分析:韩国基因组与流行病学研究的结果
Endocrine. 2025 Jun;88(3):717-726. doi: 10.1007/s12020-025-04200-3. Epub 2025 Mar 1.
3
Disease Network-Based Approaches to Study Comorbidity in Heart Failure: Current State and Future Perspectives.

本文引用的文献

1
Twelve-year clinical trajectories of multimorbidity in a population of older adults.十二年来老年人多病共存的临床轨迹。
Nat Commun. 2020 Jun 26;11(1):3223. doi: 10.1038/s41467-020-16780-x.
2
Risk Factors for Heart Failure: 20-Year Population-Based Trends by Sex, Socioeconomic Status, and Ethnicity.心力衰竭的风险因素:20 年的基于人群的性别、社会经济地位和种族趋势。
Circ Heart Fail. 2020 Feb;13(2):e006472. doi: 10.1161/CIRCHEARTFAILURE.119.006472. Epub 2020 Feb 14.
3
Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning.
基于疾病网络的心力衰竭共病研究方法:现状与未来展望
Curr Heart Fail Rep. 2024 Dec 27;22(1):6. doi: 10.1007/s11897-024-00693-7.
4
Causes and predictors of recurrent unplanned hospital admissions in heart failure patients: a cohort study.心力衰竭患者再发非计划性住院的原因和预测因素:一项队列研究。
Intern Emerg Med. 2024 Nov;19(8):2213-2221. doi: 10.1007/s11739-024-03740-2. Epub 2024 Aug 18.
5
Machine Learning-Based Phenomapping in Patients with Heart Failure and Secondary Prevention Implantable Cardioverter-Defibrillator Implantation: A Proof-of-Concept Study.心力衰竭患者及二级预防植入式心脏复律除颤器植入中的基于机器学习的表型映射:一项概念验证研究。
Rev Cardiovasc Med. 2023 Feb 2;24(2):37. doi: 10.31083/j.rcm2402037. eCollection 2023 Feb.
6
Identifying subgroups in heart failure patients with multimorbidity by clustering and network analysis.基于聚类和网络分析识别患有多种合并症的心力衰竭患者亚组。
BMC Med Inform Decis Mak. 2024 Apr 15;24(1):95. doi: 10.1186/s12911-024-02497-0.
7
The Interplay of Comorbidities in Chronic Heart Failure: Challenges and Solutions.慢性心力衰竭合并症的相互作用:挑战与解决方案。
Curr Cardiol Rev. 2024;20(3):13-29. doi: 10.2174/011573403X289572240206112303.
8
A network medicine approach to study comorbidities in heart failure with preserved ejection fraction.采用网络医学方法研究射血分数保留的心力衰竭的合并症。
BMC Med. 2023 Jul 24;21(1):267. doi: 10.1186/s12916-023-02922-7.
9
Discovering Distinct Phenotypical Clusters in Heart Failure Across the Ejection Fraction Spectrum: a Systematic Review.在射血分数谱中发现心力衰竭的不同表型簇:系统评价。
Curr Heart Fail Rep. 2023 Oct;20(5):333-349. doi: 10.1007/s11897-023-00615-z. Epub 2023 Jul 21.
10
Common non-cardiovascular multimorbidity groupings and clinical outcomes in older adults with major cardiovascular disease.老年主要心血管疾病患者常见的非心血管多病种分组与临床结局。
J Am Geriatr Soc. 2023 Oct;71(10):3179-3188. doi: 10.1111/jgs.18479. Epub 2023 Jun 24.
利用机器学习鉴定射血分数保留型心力衰竭的新型表型组。
Heart. 2020 Mar;106(5):342-349. doi: 10.1136/heartjnl-2019-315481. Epub 2020 Jan 7.
4
Risk Factors for Heart Failure in the Community: Differences by Age and Ejection Fraction.社区心力衰竭的风险因素:按年龄和射血分数的差异。
Am J Med. 2020 Jun;133(6):e237-e248. doi: 10.1016/j.amjmed.2019.10.030. Epub 2019 Nov 17.
5
Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis.基于机器学习的无监督聚类分析对射血分数保留心力衰竭患者的表型分析。
Eur J Heart Fail. 2020 Jan;22(1):148-158. doi: 10.1002/ejhf.1621. Epub 2019 Oct 21.
6
Common risk factors for heart failure and cancer.心力衰竭和癌症的常见危险因素。
Cardiovasc Res. 2019 Apr 15;115(5):844-853. doi: 10.1093/cvr/cvz035.
7
Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns.基于数据驱动的方法识别射血分数降低型心力衰竭患者的不同预后和醛固酮拮抗剂反应模式亚组。
Circ Heart Fail. 2018 Jul;11(7):e004926. doi: 10.1161/CIRCHEARTFAILURE.118.004926.
8
Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies.心力衰竭中的贫血和缺铁:当前概念和新兴疗法。
Circulation. 2018 Jul 3;138(1):80-98. doi: 10.1161/CIRCULATIONAHA.118.030099.
9
Identifying novel phenotypes of acute heart failure using cluster analysis of clinical variables.运用临床变量聚类分析识别急性心力衰竭的新表型。
Int J Cardiol. 2018 Jul 1;262:57-63. doi: 10.1016/j.ijcard.2018.03.098. Epub 2018 Mar 29.
10
Comorbidity health pathways in heart failure patients: A sequences-of-regressions analysis using cross-sectional data from 10,575 patients in the Swedish Heart Failure Registry.心力衰竭患者的合并症健康途径:使用来自瑞典心力衰竭登记处的 10575 名患者的横断面数据进行的序列回归分析。
PLoS Med. 2018 Mar 27;15(3):e1002540. doi: 10.1371/journal.pmed.1002540. eCollection 2018 Mar.